| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/ONC.2016.127 |
| P698 | PubMed publication ID | 27086927 |
| P50 | author | Jia Yu | Q82725342 |
| Lei Dong | Q86611637 | ||
| P2093 | author name string | L Li | |
| J Wang | |||
| Y Zhu | |||
| F Li | |||
| Y Ma | |||
| H Zhao | |||
| F Wang | |||
| Y Ren | |||
| R Su | |||
| D Zou | |||
| P Yi | |||
| P2860 | cites work | Erythroleukaemia in the north of England: a population based study | Q28209576 |
| Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution | Q28258018 | ||
| Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification | Q28269007 | ||
| Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1 | Q28508495 | ||
| A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis | Q29619201 | ||
| Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis | Q33464910 | ||
| Induction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2 | Q33686871 | ||
| Random small interfering RNA library screen identifies siRNAs that induce human erythroleukemia cell differentiation | Q33807659 | ||
| JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo. | Q34106870 | ||
| MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation | Q34212635 | ||
| Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia | Q34307027 | ||
| Interplay of pu.1 and gata1 determines myelo-erythroid progenitor cell fate in zebrafish | Q34380088 | ||
| Spi-1, Fli-1 and Fli-3 (miR-17-92) oncogenes contribute to a single oncogenic network controlling cell proliferation in friend erythroleukemia | Q34442132 | ||
| Retroviral insertional activation of the Fli-3 locus in erythroleukemias encoding a cluster of microRNAs that convert Epo-induced differentiation to proliferation | Q34640901 | ||
| JAK/STAT signaling in hematological malignancies. | Q34641224 | ||
| Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group | Q34692984 | ||
| Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation | Q34914457 | ||
| Functional screen reveals essential roles of miR-27a/24 in differentiation of embryonic stem cells | Q35116629 | ||
| Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. | Q35171267 | ||
| A comprehensive analysis of GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator of erythropoiesis | Q36769475 | ||
| Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. | Q37109227 | ||
| A feedback loop consisting of microRNA 23a/27a and the β-like globin suppressors KLF3 and SP1 regulates globin gene expression | Q37264387 | ||
| A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis | Q37416994 | ||
| Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. | Q37460101 | ||
| JAK inhibitors suppress t(8;21) fusion protein-induced leukemia | Q37704373 | ||
| Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 | ||
| Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential. | Q39119297 | ||
| HSP27 controls GATA-1 protein level during erythroid cell differentiation | Q39712093 | ||
| Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells. | Q40493341 | ||
| FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors | Q40514439 | ||
| PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding | Q40850691 | ||
| The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease | Q41719761 | ||
| MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets | Q41760459 | ||
| Mutations and prognosis in primary myelofibrosis | Q44429606 | ||
| Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics | Q44590610 | ||
| Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia | Q45776985 | ||
| GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation | Q47871799 | ||
| Block of red blood cell maturation in acute erythroid leukemia. | Q50501061 | ||
| Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348). | Q50860871 | ||
| Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosis. | Q53175859 | ||
| The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells. | Q54571865 | ||
| MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia. | Q54577287 | ||
| A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1 | Q73958442 | ||
| Acute myeloid leukemia and the Wnt pathway | Q84423759 | ||
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| microRNA | Q310899 | ||
| P304 | page(s) | 6001-6014 | |
| P577 | publication date | 2016-04-18 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia | |
| P478 | volume | 35 |
| Q52562647 | A step-by-step microRNA guide to cancer development and metastasis. |
| Q47719432 | Erythroleukemia-historical perspectives and recent advances in diagnosis and management |
| Q98611509 | Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer |
| Q53141065 | MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients. |
| Q99579036 | MicroRNA-23a acts as an oncogene in pancreatic carcinoma by targeting TFPI-2 |
| Q47100599 | Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia. |
| Q28073482 | The role of IL-10 in Mycobacterium avium subsp. paratuberculosis infection |
| Q37718379 | c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia |
| Q90706419 | microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance |
Search more.